Location: Local - Houston Metro

Filters close
Newswise: Houston area long-hauler is on the road to recovery thanks to UTHealth COVID-19 Center of Excellence
Released: 30-Sep-2021 11:15 AM EDT
Houston area long-hauler is on the road to recovery thanks to UTHealth COVID-19 Center of Excellence
University of Texas Health Science Center at Houston

Lying in his isolation bed in the intensive care unit (ICU) of Memorial Hermann-Texas Medical Center, Anthony Garcia could not believe he was one of the thousands of Houstonians that ended up in the hospital battling COVID-19. The husband, father of two, and friend to many had a lot of time on his hands to rest and think. “I was scared, and all of the what-ifs came to my mind,” said Garcia. “What if I don’t get better; what if I don’t get to go home?” But the biggest what-if on his mind was, “What if I would have gotten vaccinated? Would things have gone differently?”

Newswise: Lighthouse Acquires Burns Consulting Group, Strengthens Managed Care Contracting Services
Released: 23-Sep-2021 1:20 PM EDT
Lighthouse Acquires Burns Consulting Group, Strengthens Managed Care Contracting Services
2021 AACC Annual Scientific Meeting Press Program

Lighthouse Lab Services, the nation’s leading and full-service medical laboratory consulting and recruiting firm, is pleased to highlight its dual acquisitions of Vachette Pathology and Burns Consulting Group in 2021. With these acquisitions, Lighthouse has added new revenue cycle management consulting and managed care contracting services to its existing offerings for the clinical laboratory and pathology community. The company’s growth was also highlighted in Inc. Magazine’s 2021 Inc. 5000 list, which annually honors the country’s fastest growing private companies. Lighthouse President Jon Harol will be available at the 2021 AACC Lab Expo to take questions on the company’s recent expansion and new lines of service.

Newswise: 262026_web.jpg
Released: 15-Apr-2021 12:55 PM EDT
Significant spread of all coronavirus variants tracked in Houston area
Elsevier

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.

Released: 31-Mar-2021 6:00 PM EDT
Houston Methodist study reveals COVID-19 UK variant cases doubling weekly in Houston
Houston Methodist

Houston Methodist infectious disease pathologists have discovered new COVID-19 cases caused by the SARS-CoV-2 UK B.1.1.7 variant are doubling weekly. By mid-March the number increased sharply to 648 cases from 305 just a week earlier. The findings come from the latest batch of 8,857 virus genomes sequenced from patients with positive COVID-19 tests in the first two months of 2021, representing 94% of Houston Methodist cases.

Released: 2-Mar-2021 3:05 PM EST
Houston Methodist finds multiple cases of significant coronavirus mutations, including Brazil strain
Houston Methodist

Houston Methodist has sequenced more than 20,000 of Houston’s coronavirus genomes since the start of the pandemic and leads the SARS-CoV-2 genome sequencing efforts in the U.S. In the most recent batches of genomes, the U.K., South Africa, Brazil, California and New York variants were detected.

Released: 1-Mar-2019 1:05 PM EST
UTHealth shares smoking hot, and healthy, grilling tips
University of Texas Health Science Center at Houston

If National Nutrition Month has fired up your imagination to be more creative when cooking in the great outdoors but you don’t know the first thing about it, help is at hand, thanks to The University of Texas Health Science Center at Houston (UTHealth).

Newswise: Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer according to MD Anderson study
26-Feb-2019 4:30 PM EST
Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer according to MD Anderson study
University of Texas M. D. Anderson Cancer Center

A multi-center study led by researchers at The University of Texas MD Anderson Cancer Center revealed that a liquid biopsy test called Guardant360®, is comparable to standard tissue biopsies in detection of guideline recommended biomarkers in advanced non-small cell lung cancer (NSCLC), has a faster turn-around time, and has the potential to support identification of more patients who can be treated with targeted therapy.

Newswise: Texas State Rep. Senfronia Thompson calls for new state behavioral health institute
Released: 27-Feb-2019 10:05 AM EST
Texas State Rep. Senfronia Thompson calls for new state behavioral health institute
University of Texas Health Science Center at Houston

Texas Rep. Senfronia Thompson’s recent announcement calling for a statewide institute for training, telehealth, and research to improve mental well-being in children included presentations by Elizabeth Newlin, MD, and Consuelo Walss-Bass, PhD, of UTHealth in Houston.

Released: 25-Feb-2019 2:05 PM EST
New surgical technique cuts Tommy John recovery time in half
Houston Methodist

High school pitcher Gavan Lomas threw a pitch and felt pain in his right arm. While still on the mound, his first thought was that his pain would lead to the one thing he feared most in his baseball career – Tommy John surgery. His fears were confirmed when he was diagnosed with a torn ulnar collateral ligament, a ligament critical for the stability of his elbow. Not willing to give up on his senior season, he decided to forego the traditional Tommy John surgery for a new technique to get him back on the mound faster.

Released: 25-Feb-2019 12:05 PM EST
Be yourself at work -- It's healthier and more productive
Rice University

At work, it's healthier and more productive just to be yourself, according to a new study from Rice University, Texas A&M University, the University of Memphis, Xavier University, Portland State University and the University of California, Berkeley.

Released: 21-Feb-2019 4:05 PM EST
Nearly $20 million awarded by CPRIT to MD Anderson
University of Texas M. D. Anderson Cancer Center

MD Anderson received nearly $20 million from CPRIT for research, recruitment and prevention. The awards represented 20 percent of the $96 million CPRIT awarded this time. Since its inception, CPRIT has awarded $ 447.6 million to MD Anderson.

Newswise: Study finds melanoma brain metastases are immunosuppressive with treatment-resistant metabolism
Released: 20-Feb-2019 8:05 AM EST
Study finds melanoma brain metastases are immunosuppressive with treatment-resistant metabolism
University of Texas M. D. Anderson Cancer Center

Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing in other sites. Researchers at The University of Texas MD Anderson Cancer Center report in Cancer Discovery that the heavy reliance of these tumors on a specific metabolic pathway presents a potentially new therapeutic against these lethal tumors.

Newswise: Research Shows Human Trafficking Screening Tool Effective in Identifying Victims
Released: 19-Feb-2019 4:05 PM EST
Research Shows Human Trafficking Screening Tool Effective in Identifying Victims
University of Texas Health Science Center at Houston

A screening tool designed specifically to assess for human trafficking was more likely to identify sexual and labor exploitation of youth, as well as the risk factors, than a commonly used psychosocial assessment, reported researchers from The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine.

Newswise: UTHealth research highlights findings on thrombectomy, post-stroke anxiety, and caregiver burden
Released: 18-Feb-2019 7:05 PM EST
UTHealth research highlights findings on thrombectomy, post-stroke anxiety, and caregiver burden
University of Texas Health Science Center at Houston

Outcomes in patients treated with mechanical clot removal, results from the only mobile stroke unit in the country using rendezvous transfers, and data on predictors of post-stroke depression and anxiety were among the highlights of activity by investigators from The University of Texas Health Science Center at Houston (UTHealth) at the International Stroke Conference 2019.

Newswise:Video Embedded researchers-find-trigger-that-turns-strep-infections-into-flesh-eating-disease
VIDEO
14-Feb-2019 4:05 PM EST
Researchers find trigger that turns strep infections into flesh-eating disease
Houston Methodist

Houston Methodist scientists discovered a previously unknown trigger that turns run-of-the-mill strep infections into the flesh-eating disease childbed fever, which strikes postpartum moms and newborns, often leaving victims without limbs. Using an unprecedented approach, they looked at the interplay between the genome, transcriptome and virulence. This generated a massive data set, lending itself to artificial intelligence analysis. Through AI they unexpectedly discovered a new mechanism controlling virulence. The study appears Feb. 18 in Nature Genetics.

Newswise: Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors
17-Feb-2019 12:05 AM EST
Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors
University of Texas M. D. Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair (DDR) achieved significant tumor regression in mouse models of small cell lung cancer (SCLC), suggesting a promising new approach for treating patients with this aggressive cancer.

Newswise: Can we trust scientific discoveries made using machine learning?
Released: 15-Feb-2019 11:10 AM EST
Can we trust scientific discoveries made using machine learning?
Rice University

Rice University statistician Genevera Allen says scientists must keep questioning the accuracy and reproducibility of scientific discoveries made by machine-learning techniques until researchers develop new computational systems that can critique themselves.

Released: 14-Feb-2019 4:05 PM EST
Immunotherapy Combination Generates Responses Against Castration-Resistant Metastatic Prostate Cancer
University of Texas M. D. Anderson Cancer Center

Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at MD Anderson

Newswise: New therapeutic target found for aggressive pediatric cancers with few treatment options
10-Feb-2019 11:00 AM EST
New therapeutic target found for aggressive pediatric cancers with few treatment options
University of Texas M. D. Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have discovered that malignant rhabdoid tumors (MRT), a rare pediatric cancer without effective treatments, may be sensitive to drugs that block the cancer cell’s ability to dispose of misfolded proteins. The findings provide a much-needed therapeutic target for these and other cancers caused by mutations in the SMARCB1 gene.

Newswise: Neurologists Speak Out About Gender Disparity at Global Stroke Gathering
Released: 8-Feb-2019 6:05 PM EST
Neurologists Speak Out About Gender Disparity at Global Stroke Gathering
University of Texas Health Science Center at Houston

The International Stroke Conference (ISC) attracts thousands of neurologists each year to network with fellow experts and watch compelling presentations on the very latest advances in clinical care, science, and education. Joining those presentations for the first time was a rather provocative topic – gender disparities among the very presenters themselves.

Released: 7-Feb-2019 1:05 PM EST
Surgeons investigate modified pain management strategies to reduce opioid use in trauma patients
University of Texas Health Science Center at Houston

A team of surgeons is working to identify the most effective strategy to treat acute pain after injury while minimizing the amount of opioids prescribed to trauma patients, building on a previous project that decreased use of the highly addictive class of drugs by 40 percent.

Newswise: Two studies reveal pregnant women bear greater risk of hemorrhagic stroke
Released: 6-Feb-2019 6:05 PM EST
Two studies reveal pregnant women bear greater risk of hemorrhagic stroke
University of Texas Health Science Center at Houston

Pregnant women face a much greater risk of having a fatal, but less common, type of stroke caused by bleeding into the brain, according to results of two studies presented by The University of Texas Health Science Center at Houston (UTHealth) at the International Stroke Conference 2019.

Newswise: HEROES Program Awarded More Than $2 Million to Continue Opioid Intervention Outreach in Houston
Released: 5-Feb-2019 3:05 PM EST
HEROES Program Awarded More Than $2 Million to Continue Opioid Intervention Outreach in Houston
University of Texas Health Science Center at Houston

The Houston Emergency Response Opioid Engagement System (HEROES) was recently awarded two grants that will help fund the opioid intervention program through the end of 2020. James Langabeer, PhD, MBA, a professor at The University of Texas Health Science Center at Houston (UTHealth), created the program to provide comprehensive treatment for opioid abusers, gain a more thorough understanding of the epidemic in Houston, and work toward getting the highly addictive drugs off the streets.

Newswise: Research shows teens too low on sleep, activity, and too high on screen time
1-Feb-2019 7:05 PM EST
Research shows teens too low on sleep, activity, and too high on screen time
University of Texas Health Science Center at Houston

Only 1 in 20 U.S. adolescents is meeting national recommendations for sleeping, physical activity, and screen time, according to new research by The University of Texas Health Science Center at Houston (UTHealth).

Newswise: Study links protein, clusterin, to cardiac and metabolic diseases
Released: 4-Feb-2019 9:00 AM EST
Study links protein, clusterin, to cardiac and metabolic diseases
Houston Methodist

During a study spanning nearly a decade, researchers at The Ohio State University College of Medicine, Houston Methodist Research Institute and Houston Methodist Cancer Center have linked the protein clusterin – for the first time -- to many different facets of cardiometabolic syndrome risk through its actions in the liver.

Newswise:Video Embedded md-anderson-supports-world-cancer-day-call-for-action-to-end-cancer
VIDEO
Released: 4-Feb-2019 7:05 AM EST
MD Anderson supports World Cancer Day call for action to end cancer
University of Texas M. D. Anderson Cancer Center

As an institution devoted to eliminating cancer for patients in Texas, the nation and around the world, The University of Texas MD Anderson Cancer Center is proud to uphold the mission of World Cancer Day, Feb.4, to unite the global population toward the goal of eradicating the disease.

Released: 1-Feb-2019 10:40 AM EST
Women at risk for heart disease need to begin prevention early
Houston Methodist

Women with risk factors for heart disease like diabetes and a family history need to begin a prevention plan in their 30s and 40s so they can get ahead of the disease when they hit menopause

Released: 31-Jan-2019 10:05 AM EST
How Innovative Funding Sources Can Secure Sustainable Infrastructure for Cities
Houston Advanced Research Center (HARC)

HARC released a special report today for public and private sector leaders that addresses how to fund critical infrastructure required to maintain the safety and well-being of cities and communities. The Green Paper is entitled “Funding Resilience in the Greater Houston Region: Synopsis from a Public-Private Sector Workshop.”

Newswise: First US Patient in Novel Stem Cell Trial for Stroke Disability Enrolled at UTHealth
Released: 25-Jan-2019 4:05 PM EST
First US Patient in Novel Stem Cell Trial for Stroke Disability Enrolled at UTHealth
University of Texas Health Science Center at Houston

The first U.S. patient to participate in a global study of a stem cell therapy injected directly into the brain to treat stroke disability was enrolled in the clinical trial this week at The University of Texas Health Science Center at Houston (UTHealth).

Newswise: MD Anderson study shows FGL2 protein may be an effective target for glioblastoma
Released: 25-Jan-2019 1:00 PM EST
MD Anderson study shows FGL2 protein may be an effective target for glioblastoma
University of Texas M. D. Anderson Cancer Center

Glioblastoma (GBM) does not attract robust T cell immune responses. FGL2 is highly expressed in GBM and when present in tumor cells, controls a specialized group of dendritic cells which activates T cells.

Newswise: Study reveals alarming numbers of violent injuries among schoolchildren
Released: 24-Jan-2019 2:05 PM EST
Study reveals alarming numbers of violent injuries among schoolchildren
University of Texas Health Science Center at Houston

Nearly 1 in 5 fifth-graders has received violent injuries, the majority delivered by guns or knives, according to recently published research by The University of Texas Health Science Center at Houston (UTHealth).

Released: 17-Jan-2019 4:05 PM EST
Three tips for sticking with your New Year’s resolutions
Houston Methodist

By February, nearly 80 percent of Americans will give up on their New Year’s resolutions, but a Houston Methodist lifestyle coach says making a few simple changes can help people reach their goals.

Newswise: Novel same-day Type 2 diabetes treatment study launches in US
Released: 17-Jan-2019 12:05 PM EST
Novel same-day Type 2 diabetes treatment study launches in US
University of Texas Health Science Center at Houston

A same-day procedural therapy to improve glucose control for Type 2 diabetes patients will be investigated in a pilot study at The University of Texas Health Science Center at Houston (UTHealth). Absalon D. Gutierrez, MD, and Nirav C. Thosani, MD, are among the first physician-researchers in the country to assess the safety and effectiveness of The Revita™ System, designed to help improve blood sugar levels without the need for additional medications.

15-Jan-2019 9:05 AM EST
MD Anderson Cancer Center and Dragonfly Therapeutics announce strategic collaboration to take new immunotherapy candidates into clinical trials
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly’s TriNKET™ (tri-specific natural killer cell engager therapy) immunotherapy drug candidates to patients in clinical trials beginning in 2019.

Newswise: UTHealth drives forward programs to stop childhood obesity
Released: 14-Jan-2019 3:05 PM EST
UTHealth drives forward programs to stop childhood obesity
University of Texas Health Science Center at Houston

Two grants totaling nearly $3.7 million will support the efforts of The University of Texas Health Science Center at Houston (UTHealth) to combat obesity and help Texas children achieve healthy lifestyles through the mission of the Michael & Susan Dell Center for Healthy Living.

Newswise: Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated
10-Jan-2019 12:05 PM EST
Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated
University of Texas M. D. Anderson Cancer Center

Complication rates following invasive diagnostic procedures for lung abnormalities were twice as high in community settings compared to those reporter in lung screening trials, according to an MD Anderson study.

11-Jan-2019 8:00 AM EST
VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
University of Texas M. D. Anderson Cancer Center

MD Anderson researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.

Newswise: Novel Biomarker Appears Predictive of Outcome in Patients with HPV-Related Head and Neck Cancers
8-Jan-2019 5:05 PM EST
Novel Biomarker Appears Predictive of Outcome in Patients with HPV-Related Head and Neck Cancers
University of Texas M. D. Anderson Cancer Center

Rather than classifying based solely on HPV status, MD Anderson researchers have discovered a new biomarker for head and neck cancers that may enable clinicians to better predict patient outcomes and lower treatment intensity to reduce side effects.

Newswise: Who knew this about flu? Five hidden benefits of getting your flu shot
Released: 8-Jan-2019 5:05 PM EST
Who knew this about flu? Five hidden benefits of getting your flu shot
University of Texas Health Science Center at Houston

Getting the flu vaccine is not only your best shot at beating the virus – it could help in other ways you may never have realized.

Newswise: John Mendelsohn, MD Anderson President Emeritus, Passes Away
Released: 8-Jan-2019 9:40 AM EST
John Mendelsohn, MD Anderson President Emeritus, Passes Away
University of Texas M. D. Anderson Cancer Center

John Mendelsohn, M.D., president emeritus of The University of Texas MD Anderson Cancer Center and an internationally acclaimed leader in the field of medicine and scientist whose research helped pioneer a new type of cancer therapy, died Jan. 7 at his home in Houston. He was 82. The cause of death was glioblastoma, an aggressive form of brain cancer with which he was diagnosed 15 months ago.

Released: 7-Jan-2019 3:05 PM EST
MD Anderson Cancer Center and Nanobiotix announce a large-scale, comprehensive clinical collaboration on NBTXR3
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

5-Jan-2019 4:05 PM EST
MD Anderson Cancer Center and Ascentage Pharma announce strategic alliance in cancer drug development
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Ascentage Pharma Group, Inc. today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.

5-Jan-2019 2:05 AM EST
MD Anderson Cancer Center and 4D pharma collaborate to evaluate live biotherapeutics in solid tumors
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D’s live biotherapeutic oncology pipeline across a range of cancer settings.

Newswise: MD Anderson notes passing of Waun Ki Hong – innovator, mentor, colleague
Released: 3-Jan-2019 6:05 PM EST
MD Anderson notes passing of Waun Ki Hong – innovator, mentor, colleague
University of Texas M. D. Anderson Cancer Center

Waun Ki Hong, M.D., a trail-blazing physician-scientist and mentor whose clinical research innovations led to successful organ-sparing cancer treatment, advanced the field of targeted therapy and launched chemoprevention, died Wednesday at his home in California. Hong, 76, retired from The University of Texas MD Anderson Cancer Center as head of the Division of Cancer Medicine in 2014. He remained as a special advisor to a variety of MD Anderson programs that nurtured the careers of young scientists.

Released: 2-Jan-2019 3:05 PM EST
Work-Family Conflict Hits Home
University of Houston

Researchers have long known that sick children can affect a company's bottom line, as employees are distracted or have to take time off to care for their children. Far less is known about the impact a parent's work life has on their children's health.

Newswise: Nine ways to make your skin shine in 2019
Released: 21-Dec-2018 4:05 PM EST
Nine ways to make your skin shine in 2019
University of Texas Health Science Center at Houston

New year, new you – the pressure to be the best version of yourself builds in January, including the need to be comfortable in your own skin. That’s why experts at The University of Texas Health Science Center at Houston (UTHealth) are sharing their top tips on improving how your skin looks and feels both now and in the future.

Newswise: Are the late Stephen Hawking's religious beliefs typical of U.K. scientists?
Released: 19-Dec-2018 2:25 PM EST
Are the late Stephen Hawking's religious beliefs typical of U.K. scientists?
Rice University

The late Stephen Hawking famously didn't believe in God. Neither does the renowned Richard Dawkins. But is that typical for U.K. scientists?

Released: 17-Dec-2018 12:05 PM EST
Stay in shape with the 12 Days of Fitmas
Houston Methodist

For many, the holiday season is a time of overeating, but a Houston Methodist personal trainer says this year you can beat the battle of the bulge by using the classic tune “The 12 Days of Christmas.”

Newswise: UTHealth experts spill beans on festive party food preferences
Released: 13-Dec-2018 2:05 PM EST
UTHealth experts spill beans on festive party food preferences
University of Texas Health Science Center at Houston

With the holiday party season in full swing, deciding what to wear can be the biggest headache. But paying attention to what you eat at such occasions might reveal it’s your diet more in need of a makeover. The good news is experts at The University of Texas Health Science Center at Houston (UTHealth) can help.

Newswise: MD Anderson study shows key enzyme linked to therapy resistance in deadly lung cancer
9-Dec-2018 11:00 AM EST
MD Anderson study shows key enzyme linked to therapy resistance in deadly lung cancer
University of Texas M. D. Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC).


Showing results

150 of 829

close
2.63568